Literature DB >> 19157477

Structure, attachment and entry of polyoma- and papillomaviruses.

Martin Sapp1, Patricia M Day.   

Abstract

Polyoma- (PY) and Papillomavirus (PV) virions have remarkable structural equivalence although no discernable sequence similarities among the capsid proteins can be detected. Their similarities include the overall surface organization, the presence of 72 capsomeres composed of five molecules of the major capsid proteins, VP1 and L1, respectively, the structure of the core segment of capsomeres with classical antiparallel "jelly roll" beta strands as the major feature, and the linkage of neighboring capsomeres by invading C-terminal arms. Differences include the size of surface exposed loops that contain the dominant neutralizing epitopes, the details of the intercapsomeric interactions, and the presence of 2 or 1 minor capsid proteins, respectively. These differences may affect the dramatic differences observed in receptor binding and internalization pathways utilized by these viruses, but as detailed later even structural differences cannot completely explain receptor and pathway usage. In recent years, technical advances aiding the study of entry processes have allowed the identification of novel endocytic compartments and an appreciation of the links between endocytic pathways that were previously thought to be completely separable. This review is intended to highlight recent advances in our understanding of virus receptor interactions and their consequences for endocytosis and intracellular trafficking.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19157477     DOI: 10.1016/j.virol.2008.12.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  38 in total

Review 1.  Cell Walls and the Convergent Evolution of the Viral Envelope.

Authors:  Jan P Buchmann; Edward C Holmes
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

2.  Insert engineering and solubility screening improves recovery of virus-like particle subunits displaying hydrophobic epitopes.

Authors:  R S Abidin; L H L Lua; A P J Middelberg; F Sainsbury
Journal:  Protein Sci       Date:  2015-10-07       Impact factor: 6.725

Review 3.  Principles of polyoma- and papillomavirus uncoating.

Authors:  Carla Cerqueira; Mario Schelhaas
Journal:  Med Microbiol Immunol       Date:  2012-09-23       Impact factor: 3.402

Review 4.  Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G Guion; Martin Sapp
Journal:  Virus Res       Date:  2016-10-29       Impact factor: 3.303

5.  Opposing effects of bacitracin on human papillomavirus type 16 infection: enhancement of binding and entry and inhibition of endosomal penetration.

Authors:  Samuel K Campos; Janice A Chapman; Martin J Deymier; Matthew P Bronnimann; Michelle A Ozbun
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

6.  Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

Review 7.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

8.  Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types.

Authors:  Tatevik R Broutian; Sarah A Brendle; Neil D Christensen
Journal:  J Gen Virol       Date:  2009-10-21       Impact factor: 3.891

Review 9.  Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection.

Authors:  Balasubramanyam Karanam; Subhashini Jagu; Warner K Huh; Richard B S Roden
Journal:  Immunol Cell Biol       Date:  2009 May-Jun       Impact factor: 5.126

Review 10.  Mechanisms of cell entry by human papillomaviruses: an overview.

Authors:  Caroline A J Horvath; Gaëlle A V Boulet; Virginie M Renoux; Philippe O Delvenne; John-Paul J Bogers
Journal:  Virol J       Date:  2010-01-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.